Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas H Marx

Showing results (41-50 of 107) with videos related to

Pageof 11
Sort By:
International Journal of Surgical Pathology|August 10, 2022
Pan-keratin Immunostaining in Human Tumors: A Tissue Microarray Study of 15,940 TumorsAnne Menz, Natalia Gorbokon, Florian Viehweger, et al.
Expert Review of Molecular Diagnostics|July 22, 2022
Villin expression in human tumors: a tissue microarray study on 14,398 tumorsDavid Dum, Maximilian Lennartz, Anne Menz, et al.
Experimental and Molecular Pathology|April 7, 2022
Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancersDavid Dum, Anne Menz, Cosima Völkel, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 17, 2023
GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 TumorsViktor Reiswich, Carol E Schmidt, Maximilian Lennartz, et al.
Pathology, Research and Practice|September 22, 2022
Diagnostic and prognostic role of pancreatic secretory granule membrane major glycoprotein 2 (GP2) immunohistochemistry: A TMA study on 27,681 tumorsRia Uhlig, Karin Günther, Nina Bröker, et al.
Biomedicines|October 27, 2022
Inhibin Alpha Expression in Human Tumors: A Tissue Microarray Study on 12,212 TumorsSören Weidemann, Nessar Ahmad Noori, Maximilian Lennartz, et al.
Human Pathology|June 8, 2021
Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumorsAnne Menz, Rifka Bauer, Martina Kluth, et al.
Pathology, Research and Practice|November 14, 2022
Desmoglein 3 (Dsg3) expression in cancer: A tissue microarray study on 15,869 tumorsFlorian Viehweger, Ahmad Azem, Natalia Gorbokon, et al.
Molecular and Cellular Endocrinology|November 11, 2023
Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumorsKatharina Möller, Ria Uhlig, Natalia Gorbokon, et al.
Human Pathology|September 24, 2022
GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladderHenning Plage, Henrik Samtleben, Sebastian Hofbauer, et al.
Pageof 11

Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
International Journal of Surgical Pathology|August 10, 2022
Pan-keratin Immunostaining in Human Tumors: A Tissue Microarray Study of 15,940 TumorsAnne Menz, Natalia Gorbokon, Florian Viehweger, et al.
Expert Review of Molecular Diagnostics|July 22, 2022
Villin expression in human tumors: a tissue microarray study on 14,398 tumorsDavid Dum, Maximilian Lennartz, Anne Menz, et al.
Experimental and Molecular Pathology|April 7, 2022
Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancersDavid Dum, Anne Menz, Cosima Völkel, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 17, 2023
GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 TumorsViktor Reiswich, Carol E Schmidt, Maximilian Lennartz, et al.
Pathology, Research and Practice|September 22, 2022
Diagnostic and prognostic role of pancreatic secretory granule membrane major glycoprotein 2 (GP2) immunohistochemistry: A TMA study on 27,681 tumorsRia Uhlig, Karin Günther, Nina Bröker, et al.
Biomedicines|October 27, 2022
Inhibin Alpha Expression in Human Tumors: A Tissue Microarray Study on 12,212 TumorsSören Weidemann, Nessar Ahmad Noori, Maximilian Lennartz, et al.
Human Pathology|June 8, 2021
Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumorsAnne Menz, Rifka Bauer, Martina Kluth, et al.
Pathology, Research and Practice|November 14, 2022
Desmoglein 3 (Dsg3) expression in cancer: A tissue microarray study on 15,869 tumorsFlorian Viehweger, Ahmad Azem, Natalia Gorbokon, et al.
Molecular and Cellular Endocrinology|November 11, 2023
Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumorsKatharina Möller, Ria Uhlig, Natalia Gorbokon, et al.
Human Pathology|September 24, 2022
GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladderHenning Plage, Henrik Samtleben, Sebastian Hofbauer, et al.
Pageof 11